AnHui Wanyi Science and Technology Co., Ltd.

SSE:688600.SS

19.4 (CNY) • At close May 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 134.287284.615159.046180.134113.916279.787194.654175.598134.822232.548173.33154.851114.672216.591152.103127.56266.196192.11287.813113.19424.154156.915104.708103.97243.44
Cost of Revenue 67.094156.68982.508100.90559.429144.34104.78990.20965.413129.7288.674.31258.909113.02870.28263.04431.34392.37842.50154.98510.96480.17551.39847.8118.327
Gross Profit 67.193127.92776.53979.22954.487135.44789.86685.38969.408102.82884.72980.53955.763103.56381.82264.51734.85399.73345.31258.20813.1976.7453.30956.16325.113
Gross Profit Ratio 0.50.4490.4810.440.4780.4840.4620.4860.5150.4420.4890.520.4860.4780.5380.5060.5270.5190.5160.5140.5460.4890.5090.540.578
Reseach & Development Expenses 35.441037.00134.07543.78645.86543.51942.23832.16931.62534.82432.13435.63929.3739.84126.84421.25621.419.09616.06512.23213.0613.28913.72211.219
General & Administrative Expenses 11.614028.174-1.711.685-17.20722.6870.5487.967-15.27618.687-0.6418.636-13.95919.776-3.0037.971-12.5969.066-2.4517.1886.1025.804-2.31212.765
Selling & Marketing Expenses 30.645079.58632.0442.50738.12838.95740.95839.21435.04142.47743.86538.98843.03441.27536.27827.09822.90723.65223.55914.19423.8123.65219.8721.557
SG&A 42.26-84.72107.7645.46951.65355.73461.64441.50647.18119.76561.16443.22347.62529.07561.05133.27535.06910.31132.71821.10821.38232.42329.45617.55834.322
Other Expenses -5.214130.641-70.569-3.434-2.124-7.565-0.2450.102-5.49118.982-28.838-7.001-9.3224.5841.1991.9320.4817.1850.4947.1170.389-119.5610.470.5370.012
Operating Expenses 72.48675.07974.19282.97897.563109.16586.29784.80673.85970.37367.14968.35673.94264.11383.36162.53753.13442.60245.62941.63731.865-119.56130.41434.99440.618
Operating Income -5.29352.8482.347-3.749-43.07526.2821.5763.235-4.01825.51916.2916.509-18.17938.5980.0267.016-14.38454.211-0.49513.338-17.66437.35323.42318.56-14.243
Operating Income Ratio -0.0390.1860.015-0.021-0.3780.0940.0080.018-0.030.110.0940.107-0.1590.17800.055-0.2170.282-0.0060.118-0.7310.2380.2240.179-0.328
Total Other Income Expenses Net -0.0560.273-0.0679.0710.7921.0750.3750.1020.262-1.604-0.0545.6681.9354.3372.3871.8191.5327.1850.7177.1170.3898.2120.14-1.0930.012
Income Before Tax -5.34953.122.285.322-33.65944.371.3313.337-3.47523.91418.49515.041-15.84443.1831.2258.949-13.90261.396-0.00120.455-17.27545.56523.89319.097-14.231
Income Before Tax Ratio -0.040.1870.0140.03-0.2950.1590.0070.019-0.0260.1030.1070.097-0.1380.1990.0080.07-0.210.32-00.181-0.7150.290.2280.184-0.328
Income Tax Expense 0.1021.3020.0990.8265.43518.704-5.835-6.026-4.9651.292-2.063-1.584-6.8640.119-2.736-5.134-1.6962.110.2673.291-2.446223.4983.7883.078-1.959
Net Income -5.45145.0142.1814.752-33.61625.7937.1669.3631.48922.20319.30415.486-8.9842.2383.79413.508-12.05657.499-0.37115.753-14.02342.65619.28916.613-12.053
Net Income Ratio -0.0410.1580.0140.026-0.2950.0920.0370.0530.0110.0950.1110.1-0.0780.1950.0250.106-0.1820.299-0.0040.139-0.5810.2720.1840.16-0.277
EPS -0.040.350.0170.037-0.260.20.0530.070.0110.170.150.12-0.0690.320.0280.1-0.090.43-0.0030.16-0.140.420.190.17-0.12
EPS Diluted -0.040.350.0170.037-0.260.20.0530.070.0110.170.150.12-0.0690.320.0280.1-0.090.43-0.0030.16-0.140.420.190.17-0.12
EBITDA -4.95951.5472.65511.741-32.90451.0177.5438.2681.55923.95122.89219.001-11.44547.0945.10512.014-18.28163.8270.92318.814-16.24947.64425.97222.072-13.753
EBITDA Ratio -0.0370.1810.0170.065-0.2890.1820.0390.0470.0120.1030.1320.123-0.10.2170.0340.094-0.2760.3320.0110.166-0.6730.3040.2480.212-0.317